Type 2 Diabetes Mellitus Prevention Ukraine

Development, Implementation and Evaluation of the Effectiveness of Recommendations for the Prevention of Type 2 Diabetes in Ukraine

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04283201

Acronym

T2DPUA

Enrollment

Registered

2020-02-25

Start date

2020-02-20

Completion date

2021-12-31

Last updated

2022-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Fasting Glucose, Impaired Glucose Tolerance, Type 2 Diabetes

Keywords

lifestyle modification, type 2 diabetes, prevention, Ukraine, Rural

Brief summary

Development, implementation and evaluation of the effectiveness of lifestyle recommendations for the prevention of type 2 diabetes in rural population of Ukraine

Detailed description

An oral glucose tolerance test and anthropometric measurements were performed for 300 randomly selected rural residents of the Kyiv region of Ukraine. Persons from impaired glucose regulation category (impaired fasting glucose - IFG) was enrolled to diabetes prevention intervention study (T2DPUA). Individuals in the IFG category received advice on limiting sugar intake (not more than 25 g per day), increasing physical activity (30 minutes daily). 30 persons from this category were additionally advised to consume insoluble dietary fiber 15 g per day (Vitacel wheat fiber) for 3 months, after which a repeat anthropometric and biochemical study. Objective control of physical activity and body composition is also provided.

Interventions

OTHERPhysical activity

Moderate activity 150 min per week

OTHERMacronutrient modification

Insoluble dietary fiber 15 g per day (Vitacel wheat fiber); sugar limitation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Intervention model description

30 persons from this category were additionally advised to consume insoluble dietary fiber 15 g per day (Vitacel wheat fiber) for 3 months, after which a repeat anthropometric and biochemical study.

Eligibility

Sex/Gender

ALL

Age

18 Years to 79 Years

Healthy volunteers

Yes

Inclusion criteria

Persons with fasting blood glucose level \>=6.1 mmol/l; persons aged 18-79 who signed an informed consent for the study.

Exclusion criteria

Known diabetes; acute infectious diseases; other serious diseases

Design outcomes

Primary

Measure	Time frame	Description
New type 2 diabetes cases	3 month	fasting blood glucose level \>=6.1 mmol/l

Countries

Ukraine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026